Overview
MiRNA
A Pilot Study: "Analysis of Serum miRNA from Women Referred for Breast Biopsy with Abnormal Breast Imaging Classified as BI-RADS 4 or 5"
Objective
By drawing a tube of blood, data is obtained that will hopefully improve the breast cancer screening process in the future. Researchers are looking at serum miRNA signatures to determine if a subsequent breast biopsy has a higher likelihood of being positive or negative. This study is recruiting patients have breast imaging studies suspicious for cancer discovered during screening.
Principal Investigator(s)
Steven Scallon, MD, Radiologist, Breast Health
Study Contact(s)
Stephanie Porenta, RN BSN CCRC: 425.467.3986, Stephanie.Porenta@overlakehospital.org
Pooja Rajeevan, CRC: 425.635.6081, Pooja.Rajeevan@overlakehospital.org
Clinical Trial Categories
Oncology
Find locations + directions
Contact us
